22 May 2013
Keywords: erbitux, data, merck, presented, asco, imclone, systems
Article | 10 March 2003
ImClone Systems' European marketing partner for colorectal cancer drugErbitux (cetuximab), Germany's Merck KGaA, is scheduled to present the
results of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2003
© 2013 thepharmaletter.com